Candida auris and emerging diagnostics: A strategic look ahead in antimicrobial resistance
As Candida auris and carbapenem-resistant Enterobacterales rise, join us online to explore how emerging approaches such as next-generation sequencing and rapid susceptibility testing may support antimicrobial stewardship — plus, ask your questions in the live Q&A
15 May 2026
Editorial article
Antimicrobial resistance (AMR) continues to accelerate, driving urgent demand for faster, more actionable diagnostics to support antimicrobial stewardship and improve patient outcomes. As emerging threats such as Candida auris and carbapenem-resistant Enterobacterales (CRE) increase, understanding how new diagnostic approaches can be implemented in clinical practice is more critical than ever.
Brought to you by Danaher companies Beckman Coulter Diagnostics and Cepheid, this expert-led online session explores emerging diagnostic approaches to address AMR, including lessons learned from methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) testing.
Register nowSpeakers will examine molecular approaches for AMR gene detection using syndromic polymerase chain reaction (PCR) panels and next-generation sequencing (NGS), alongside emerging rapid phenotypic antimicrobial susceptibility testing (AST) technologies. They will also discuss bacterial versus viral host-response diagnostics and key considerations for clinical implementation.
In this session, you will:
- Understand how emerging diagnostics may improve AMR detection in clinical workflows
- Explore the role of NGS, syndromic PCR, and rapid AST in real-world settings
- Learn practical considerations for implementing new diagnostic approaches in clinical laboratories
- Gain insights from global experts and learn how to apply them to laboratory and antimicrobial stewardship decision-making
This session is particularly valuable for those who were unable to attend ESCMID Global 2026 in person.
Register now to secure your place and join the live Q&A with global AMR experts.
Webinar details
Date/Time: Wednesday, May 27 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
Duration: 90 minutes
Cost: Free (registration required)
On-demand: If you register but can’t attend live, you will receive a link to the on-demand recording once available.
Expert speakers include:
- Prof. Patrice Nordmann, Swiss National Reference Center for Emerging Antibiotic Resistance
- Dr. David Jenkins, University Hospitals of Leicester NHS Trust
- Prof. Enitan Carrol, University of Liverpool
- Dr. Romney Humphries, Vanderbilt University Medical Center
- Dr. Ephraim Tsalik, Danaher Diagnostics and Duke University School of Medicine
- Dr. Stephanie Mitchell, Beckman Coulter Diagnostics
- Lucas Schulz, Cepheid
Attend live to ask your questions during the interactive Q&A session.
Frequently asked questions
Who should attend this webinar?
This webinar is designed for healthcare and laboratory professionals interested in antimicrobial resistance (AMR) diagnostics, including clinical microbiologists, infectious disease specialists, infection prevention professionals, and researchers focused on AMR and translational science.
What topics will be covered?
The session explores emerging diagnostic approaches to address AMR, including:
- Molecular detection of AMR genes (e.g., syndromic PCR panels and NGS)
- Rapid phenotypic antimicrobial susceptibility testing (AST)
- Host-response diagnostics to distinguish bacterial vs viral infections
- Practical considerations for implementing new diagnostic technologies in clinical settings
What makes this webinar valuable?
This session brings together key expert perspectives and insights from ESCMID Global 2026, combined with a live Q&A, giving attendees the opportunity to engage directly with leading experts and explore how emerging diagnostics may be applied in real-world clinical workflows.
Will there be an opportunity to ask questions?
Yes — a live Q&A session will follow the presentation, allowing attendees to ask questions directly to the panel of experts.
Do I need to attend live?
We recommend attending live to participate in the Q&A discussion. However, if you register and are unable to attend, you will receive access to the on-demand recording.
Is there a cost to attend?
No — this webinar is free to attend.
Will I receive a certificate of attendance?
Yes. Attendees who join the live webinar will automatically receive a certificate of attendance, including a learning outcomes summary for continuing education purposes. On-demand viewers can request a certificate by emailing editor@selectscience.net.
How long is the webinar?
The webinar will run for approximately 90 minutes.
Why is this topic important now?
Antimicrobial resistance continues to evolve rapidly, creating urgent demand for faster, more actionable diagnostics. Understanding how emerging technologies can support antimicrobial stewardship is critical for improving patient outcomes and healthcare efficiency.